Adverse effect of cardi-stim glycos/drug simlar act, subs

This diagnosis code signifies a harmful or unintended reaction experienced by a patient due to the therapeutic use of cardiac glycosides or similar medications, occurring during a follow-up visit after initial treatment for the adverse effect. It indicates that the patient is still being managed for the negative consequences of these heart-stimulating drugs.

This code is appropriate for documenting ongoing care for adverse effects such as digitalis toxicity (e.g., arrhythmias, nausea, visual disturbances) or other negative reactions to medications like digoxin, digitoxin, or related compounds. It should be used when the patient presents for subsequent evaluation or treatment of these previously identified drug-induced issues.

• Always sequence this code after the code for the specific manifestation of the adverse effect (e.g., R00.2 for palpitations).
• Ensure documentation clearly links the adverse effect to the cardiac-stimulant glycoside and specifies that this is not the initial encounter for the adverse event.
• Distinguish carefully between adverse effect (therapeutic use) and poisoning (incorrect use or overdose).